| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |